| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter binding | 5.27e-05 | 172 | 152 | 8 | GO:0044325 | |
| GeneOntologyMolecularFunction | interleukin-1, type I, activating receptor activity | 5.76e-05 | 2 | 152 | 2 | GO:0004909 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HTR2B PDGFRA OR5L1 OR2G2 GRIK1 GRIK2 ACVR1 PKD1L3 IL1RL2 OR10J1 OR10X1 OR10Z1 THBD TAS2R16 ADRA1A TAS2R7 CELSR3 SCARB2 OR10K1 OR10K2 RXFP1 IL1R1 ADGRF1 GPR119 | 8.83e-05 | 1353 | 152 | 24 | GO:0004888 |
| GeneOntologyBiologicalProcess | heart development | SIN3B PDE2A ANGPT1 HTR2B ANK2 PDGFRA SYNE1 FUZ ACTN2 ACVR1 NEB EMILIN1 THBS1 ADRA1A C2CD3 ADAMTS9 DNAH5 DNM2 CCDC40 | 2.88e-06 | 757 | 151 | 19 | GO:0007507 |
| GeneOntologyBiologicalProcess | cGMP-mediated signaling | 1.05e-05 | 40 | 151 | 5 | GO:0019934 | |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 1.32e-05 | 7 | 151 | 3 | GO:0071321 | |
| GeneOntologyBiologicalProcess | establishment of spindle orientation | 2.12e-05 | 46 | 151 | 5 | GO:0051294 | |
| GeneOntologyBiologicalProcess | response to cGMP | 3.13e-05 | 9 | 151 | 3 | GO:0070305 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 SYNE1 FUZ ACTN2 CFAP43 PARVG ARID1B C2CD3 CELSR3 ULK4 RAPGEF2 DNAH5 CDH13 HTT DNM2 CCDC40 | 4.39e-05 | 685 | 151 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 SYNE1 RTTN FUZ CFAP43 C2CD3 CELSR3 ULK4 DNAH5 BBS12 HTT DNM2 CCDC40 | 4.97e-05 | 476 | 151 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of glucosylceramidase activity | 5.32e-05 | 2 | 151 | 2 | GO:1905123 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 7.45e-05 | 31 | 151 | 4 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 7.45e-05 | 31 | 151 | 4 | GO:1900048 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 8.46e-05 | 32 | 151 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | establishment of spindle localization | 9.10e-05 | 62 | 151 | 5 | GO:0051293 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 1.08e-04 | 34 | 151 | 4 | GO:0050820 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 SYNE1 FUZ ACTN2 CFAP43 ARID1B C2CD3 CELSR3 ULK4 RAPGEF2 DNAH5 CDH13 HTT DNM2 CCDC40 | 1.23e-04 | 670 | 151 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | circulatory system development | SIN3B PDE2A ANGPT1 HTR2B ANK2 PDGFRA SYNE1 LAMA1 EMILIN2 FUZ ACTN2 ACVR1 NEB EMILIN1 THBS1 ADRA1A C2CD3 ADAMTS9 RAPGEF2 DNAH5 SLC2A12 CDH13 DNM2 CCDC40 | 1.29e-04 | 1442 | 151 | 24 | GO:0072359 |
| GeneOntologyBiologicalProcess | spindle localization | 1.32e-04 | 67 | 151 | 5 | GO:0051653 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 1.86e-04 | 39 | 151 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 PDGFRA SYNE1 RTTN NUMA1 FUZ ACTN2 CFAP43 NEB SYT7 SPAG5 C2CD3 CELSR3 AP5Z1 ULK4 CDK5RAP2 DNAH5 HTT DNM2 CCDC40 | 2.46e-04 | 1138 | 151 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 RTTN NUMA1 FUZ CFAP43 LYST SPAG5 C2CD3 LLGL1 AKAP9 CATSPER4 ULK4 CDK5RAP2 DNAH5 BBS12 TTLL13 HTT DNM2 CCDC40 | 2.71e-04 | 1058 | 151 | 19 | GO:0007017 |
| GeneOntologyCellularComponent | EMILIN complex | 5.32e-05 | 2 | 153 | 2 | GO:1990971 | |
| GeneOntologyCellularComponent | synaptic membrane | PDE2A ANK2 SYNE1 GRIK1 GRIK2 ACTN2 SYT7 ADRA1A AKAP9 CELSR3 SCN10A UNC13A HTT DNM2 | 1.01e-04 | 583 | 153 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.42e-04 | 17 | 153 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | centriole | 2.80e-04 | 172 | 153 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 7.83e-04 | 6 | 153 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | Z disc | 8.68e-04 | 151 | 153 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | cilium | DNHD1 PDGFRA RTTN FUZ CCT4 CFAP43 PTGS1 SPAG5 C2CD3 AKAP9 CATSPER4 ULK4 DNAH5 BBS12 TTLL13 CCDC40 | 9.20e-04 | 898 | 153 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | glutamatergic synapse | GRIK1 GRIK2 ACTN2 SYT7 ELMO1 LIMK1 ADRA1A AKAP9 CELSR3 GUCY1B1 RABEP1 SCN10A UNC13A HTT DNM2 | 9.90e-04 | 817 | 153 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.02e-03 | 277 | 153 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.10e-03 | 28 | 153 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | microtubule organizing center | SPOUT1 RTTN NUMA1 CCT4 CCDC92 ECPAS BIRC6 SPAG5 C2CD3 AKAP9 CROCC2 SLMAP CDK5RAP2 TSKS HTT DNM2 | 1.17e-03 | 919 | 153 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | sodium channel complex | 1.22e-03 | 29 | 153 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.37e-03 | 360 | 153 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | I band | 1.41e-03 | 166 | 153 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | external side of plasma membrane | PDGFRA CAPN2 MUC16 MAP3K5 MFAP3 THBD TAS2R16 THBS1 GYPB IL1R1 CDH13 | 1.56e-03 | 519 | 153 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | centrosome | SPOUT1 RTTN NUMA1 CCT4 CCDC92 ECPAS BIRC6 SPAG5 C2CD3 AKAP9 CROCC2 SLMAP CDK5RAP2 DNM2 | 1.60e-03 | 770 | 153 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | cation channel complex | 1.76e-03 | 235 | 153 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | SERPINA3 LAMB4 FRAS1 ANGPT1 LAMA1 EMILIN2 COL5A3 EMILIN1 THBS1 ADAMTS9 CDH13 | 1.84e-03 | 530 | 153 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | ankyrin-1 complex | 2.30e-03 | 10 | 153 | 2 | GO:0170014 | |
| MousePheno | decreased adipocyte glucose uptake | 2.32e-05 | 20 | 121 | 4 | MP:0030017 | |
| MousePheno | abnormal adipocyte glucose uptake | 2.94e-05 | 42 | 121 | 5 | MP:0004185 | |
| Domain | ARM-like | RTTN SCYL3 HSF2BP ECPAS ELMO1 NOP9 ARID1B PLAA XPO5 AP5Z1 ULK4 UTP20 TARBP1 HTT TANGO6 | 5.32e-09 | 270 | 151 | 15 | IPR011989 |
| Domain | ARM-type_fold | RTTN SCYL3 INTS1 HSF2BP ECPAS FMNL2 LYST ELMO1 NOP9 PLAA XPO5 ULK4 UTP20 TARBP1 HTT TANGO6 | 1.63e-08 | 339 | 151 | 16 | IPR016024 |
| Domain | - | RTTN SCYL3 HSF2BP ECPAS ELMO1 NOP9 ARID1B XPO5 AP5Z1 ULK4 UTP20 HTT TANGO6 | 3.14e-08 | 222 | 151 | 13 | 1.25.10.10 |
| Domain | HEAT_REPEAT | 2.16e-05 | 70 | 151 | 6 | PS50077 | |
| Domain | IL-1_rcpt_I-typ | 6.49e-05 | 2 | 151 | 2 | IPR004076 | |
| Domain | - | 3.85e-04 | 4 | 151 | 2 | 3.40.1280.10 | |
| Domain | tRNA_m1G_MTases_N | 3.85e-04 | 4 | 151 | 2 | IPR029026 | |
| Domain | HEAT | 6.06e-04 | 48 | 151 | 4 | PF02985 | |
| Domain | IL-1_rcpt_I/II-typ | 9.53e-04 | 6 | 151 | 2 | IPR004074 | |
| Domain | Alpha/beta_knot_MTases | 9.53e-04 | 6 | 151 | 2 | IPR029028 | |
| Domain | EGF_1 | 1.12e-03 | 255 | 151 | 8 | PS00022 | |
| Domain | HEAT | 1.24e-03 | 58 | 151 | 4 | IPR000357 | |
| Domain | Laminin_G | 1.24e-03 | 58 | 151 | 4 | IPR001791 | |
| Domain | EGF_2 | 1.43e-03 | 265 | 151 | 8 | PS01186 | |
| Domain | BIR | 1.76e-03 | 8 | 151 | 2 | PF00653 | |
| Domain | BIR_REPEAT_2 | 1.76e-03 | 8 | 151 | 2 | PS50143 | |
| Domain | BIR | 1.76e-03 | 8 | 151 | 2 | SM00238 | |
| Domain | - | 1.76e-03 | 8 | 151 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 1.76e-03 | 8 | 151 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 1.76e-03 | 8 | 151 | 2 | PS01282 | |
| Domain | EGF_LAM_2 | 1.79e-03 | 30 | 151 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.79e-03 | 30 | 151 | 3 | PS01248 | |
| Domain | GPS | 2.58e-03 | 34 | 151 | 3 | SM00303 | |
| Domain | Cadherin | 2.72e-03 | 118 | 151 | 5 | IPR002126 | |
| Domain | EMI | 2.80e-03 | 10 | 151 | 2 | PF07546 | |
| Domain | EGF_Lam | 2.80e-03 | 35 | 151 | 3 | SM00180 | |
| Domain | GPS | 2.80e-03 | 35 | 151 | 3 | PF01825 | |
| Domain | Laminin_EGF | 2.80e-03 | 35 | 151 | 3 | PF00053 | |
| Domain | GPS | 3.04e-03 | 36 | 151 | 3 | PS50221 | |
| Domain | EGF | 3.05e-03 | 235 | 151 | 7 | SM00181 | |
| Domain | GPS | 3.29e-03 | 37 | 151 | 3 | IPR000203 | |
| Domain | IL-1_rcpt_fam | 3.40e-03 | 11 | 151 | 2 | IPR015621 | |
| Domain | Laminin_EGF | 3.55e-03 | 38 | 151 | 3 | IPR002049 | |
| Domain | ZU5 | 4.06e-03 | 12 | 151 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.06e-03 | 12 | 151 | 2 | IPR000906 | |
| Domain | Laminin_G_2 | 4.11e-03 | 40 | 151 | 3 | PF02210 | |
| Domain | EGF-like_dom | 4.18e-03 | 249 | 151 | 7 | IPR000742 | |
| Domain | ig | 4.52e-03 | 190 | 151 | 6 | PF00047 | |
| Domain | Immunoglobulin | 4.52e-03 | 190 | 151 | 6 | IPR013151 | |
| Domain | LamG | 5.38e-03 | 44 | 151 | 3 | SM00282 | |
| Domain | EGF-like_CS | 5.39e-03 | 261 | 151 | 7 | IPR013032 | |
| Domain | Dynein_HC_stalk | 5.54e-03 | 14 | 151 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.54e-03 | 14 | 151 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.54e-03 | 14 | 151 | 2 | PF08393 | |
| Domain | GROEL-like_equatorial | 5.54e-03 | 14 | 151 | 2 | IPR027413 | |
| Domain | Sugar/inositol_transpt | 5.54e-03 | 14 | 151 | 2 | IPR003663 | |
| Domain | TUDOR | 5.54e-03 | 14 | 151 | 2 | PF00567 | |
| Domain | MT | 5.54e-03 | 14 | 151 | 2 | PF12777 | |
| Domain | - | 5.54e-03 | 14 | 151 | 2 | 1.10.560.10 | |
| Domain | DHC_fam | 6.36e-03 | 15 | 151 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.36e-03 | 15 | 151 | 2 | PF03028 | |
| Domain | GroEL-like_apical_dom | 6.36e-03 | 15 | 151 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 6.36e-03 | 15 | 151 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 6.36e-03 | 15 | 151 | 2 | PF00118 | |
| Domain | - | 6.36e-03 | 15 | 151 | 2 | 3.50.7.10 | |
| Domain | Dynein_heavy_dom | 6.36e-03 | 15 | 151 | 2 | IPR004273 | |
| Domain | EMI_domain | 7.23e-03 | 16 | 151 | 2 | IPR011489 | |
| Domain | Laminin_N | 7.23e-03 | 16 | 151 | 2 | IPR008211 | |
| Domain | LamNT | 7.23e-03 | 16 | 151 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 7.23e-03 | 16 | 151 | 2 | PS51117 | |
| Domain | Laminin_N | 7.23e-03 | 16 | 151 | 2 | PF00055 | |
| Domain | - | 7.40e-03 | 95 | 151 | 4 | 2.60.120.200 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.71e-05 | 199 | 111 | 9 | M7253 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 3.26e-05 | 47 | 111 | 5 | M39531 | |
| Pubmed | CENP-32 is required to maintain centrosomal dominance in bipolar spindle assembly. | 1.89e-09 | 5 | 155 | 4 | 25657325 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | UBQLNL SIN3B LAMB4 SPOUT1 LAMA1 INTS1 ECPAS PARVG FMNL2 BIRC6 MTPAP PTGS1 ADRA1A GTF3C1 ADAMTS9 UTP20 KDM8 RXFP1 | 5.91e-09 | 736 | 155 | 18 | 29676528 |
| Pubmed | SERPINA3 ANK2 SYNE1 ACTN2 NEB BIRC6 MAP3K5 ARID1B AKAP9 ADAMTS9 RABEP1 SLMAP CDK5RAP2 DNM2 | 5.70e-08 | 497 | 155 | 14 | 23414517 | |
| Pubmed | SIN3B PDE2A TCAF1 ANK2 SYNE1 PPFIA1 NUMA1 CCT4 CHD8 GRIK2 MAP3K5 KIAA0319 AKAP9 RABEP1 CDK5RAP2 RAPGEF2 UNC13A CUX1 DNM2 | 6.63e-08 | 963 | 155 | 19 | 28671696 | |
| Pubmed | 1.16e-06 | 234 | 155 | 9 | 36243803 | ||
| Pubmed | KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination. | 3.00e-06 | 7 | 155 | 3 | 28826497 | |
| Pubmed | Gene-environment interaction in the etiology of mathematical ability using SNP sets. | 3.00e-06 | 7 | 155 | 3 | 20978832 | |
| Pubmed | DCHS2 PDE2A ANK2 SYNE1 FUZ GRIK1 FMNL2 LRP1B LIMK1 THBS1 FBH1 CELSR3 GUCY1B1 ADAMTS9 RABEP1 RAPGEF2 TARBP1 CUX1 DNM2 | 4.91e-06 | 1285 | 155 | 19 | 35914814 | |
| Pubmed | 6.36e-06 | 101 | 155 | 6 | 10997877 | ||
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 7.15e-06 | 9 | 155 | 3 | 27325115 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 PDE2A SPOUT1 RTTN INTS1 CHD8 CFAP43 ATP13A2 BIRC6 LYST MAP3K5 C2CD3 CELSR3 CHST15 ULK4 ABTB2 HTT | 9.64e-06 | 1105 | 155 | 17 | 35748872 |
| Pubmed | 1.06e-05 | 167 | 155 | 7 | 22159717 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 HTR2B PPFIA1 NUMA1 HSF2BP NEB ECPAS PARVG GTF3C1 TIAL1 CROCC2 | 1.55e-05 | 497 | 155 | 11 | 36774506 |
| Pubmed | SIN3B PPFIA1 CHD8 ECPAS BIRC6 SPAG5 GTF3C1 RABEP1 CUX1 TANGO6 | 1.97e-05 | 418 | 155 | 10 | 34709266 | |
| Pubmed | Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains. | 1.97e-05 | 2 | 155 | 2 | 25445627 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15673679 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9478926 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26095046 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11182092 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 14724198 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15539395 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 1.97e-05 | 2 | 155 | 2 | 37676945 | |
| Pubmed | Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia. | 1.97e-05 | 2 | 155 | 2 | 34763298 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 7696618 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 1.97e-05 | 2 | 155 | 2 | 8260617 | |
| Pubmed | Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane. | 1.97e-05 | 2 | 155 | 2 | 22861190 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 1.97e-05 | 2 | 155 | 2 | 15537878 | |
| Pubmed | Miltenberger blood group antigen type III (Mi.III) enhances the expression of band 3. | 1.97e-05 | 2 | 155 | 2 | 19564639 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15358807 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 34381117 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 1.97e-05 | 2 | 155 | 2 | 24760837 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19646509 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 34793694 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11069933 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 12947409 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 1.97e-05 | 2 | 155 | 2 | 15928066 | |
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 1.97e-05 | 2 | 155 | 2 | 8700852 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 36044851 | ||
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 1.97e-05 | 2 | 155 | 2 | 16221857 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 16219388 | ||
| Pubmed | EMILIN2 regulates platelet activation, thrombus formation, and clot retraction. | 1.97e-05 | 2 | 155 | 2 | 25658937 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22566882 | ||
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 1.97e-05 | 2 | 155 | 2 | 15014126 | |
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 1.97e-05 | 2 | 155 | 2 | 11144357 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 12038792 | ||
| Pubmed | SNaPshot Assay in Quantitative Detection of Allelic Nondisjunction in Down Syndrome. | 1.97e-05 | 2 | 155 | 2 | 22931243 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25043179 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11278945 | ||
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 1.97e-05 | 2 | 155 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 1.97e-05 | 2 | 155 | 2 | 11985817 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28867767 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FRAS1 LAMA1 GRIK2 LRP1B PTGFRN PTGS1 SPAG5 GPR107 THBS1 GTF3C1 CELSR3 SCARB2 UTP20 TMEM164 CDH13 HTT TANGO6 | 2.78e-05 | 1201 | 155 | 17 | 35696571 |
| Pubmed | 4.16e-05 | 282 | 155 | 8 | 23667531 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ANK2 PPFIA1 SCYL3 PLEKHA6 FMNL2 SYT7 GPR107 PACS1 THBD LLGL1 CASKIN2 | 5.30e-05 | 569 | 155 | 11 | 30639242 |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 30768638 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 37759764 | ||
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 5.90e-05 | 3 | 155 | 2 | 27346345 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 1379666 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 8730589 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 31513786 | ||
| Pubmed | Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. | 5.90e-05 | 3 | 155 | 2 | 17704206 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 21685324 | ||
| Pubmed | Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. | 5.90e-05 | 3 | 155 | 2 | 16803853 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 29054927 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 5.90e-05 | 3 | 155 | 2 | 7523595 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 35908547 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 18757424 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 19252089 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 15509753 | ||
| Pubmed | A novel postsynaptic signal pathway of sympathetic neural regulation of murine colonic motility. | 5.90e-05 | 3 | 155 | 2 | 32086857 | |
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 5.90e-05 | 3 | 155 | 2 | 9880586 | |
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 5.90e-05 | 3 | 155 | 2 | 15805114 | |
| Pubmed | EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro. | 5.90e-05 | 3 | 155 | 2 | 17988845 | |
| Pubmed | 6.45e-05 | 152 | 155 | 6 | 34299191 | ||
| Pubmed | 6.74e-05 | 18 | 155 | 3 | 20602751 | ||
| Pubmed | 7.45e-05 | 50 | 155 | 4 | 23658023 | ||
| Pubmed | 7.98e-05 | 19 | 155 | 3 | 19095219 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 8.82e-05 | 100 | 155 | 5 | 25807483 | |
| Pubmed | 9.25e-05 | 101 | 155 | 5 | 26949739 | ||
| Pubmed | Germline Chd8 haploinsufficiency alters brain development in mouse. | 9.36e-05 | 20 | 155 | 3 | 28671691 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SYNE1 PPFIA1 RTTN SCYL3 PLEKHA6 BIRC6 PTGFRN THBD LLGL1 XPO5 TMEM164 TARBP1 | 9.80e-05 | 719 | 155 | 12 | 35337019 |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 26277340 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 34206078 | ||
| Pubmed | Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion. | 1.18e-04 | 4 | 155 | 2 | 21996738 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 25556835 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 28939216 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 15513934 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 19369569 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 21455273 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 17650106 | ||
| Pubmed | Nuclear Mitotic Apparatus (NuMA) Interacts with and Regulates Astrin at the Mitotic Spindle. | 1.18e-04 | 4 | 155 | 2 | 27462074 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 16305343 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 16354929 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 26908325 | ||
| Pubmed | Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. | 1.18e-04 | 4 | 155 | 2 | 16150726 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 28966089 | ||
| Pubmed | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. | 1.18e-04 | 4 | 155 | 2 | 20081851 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 1.18e-04 | 4 | 155 | 2 | 30241548 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 9501083 | ||
| Pubmed | A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. | 1.18e-04 | 4 | 155 | 2 | 1833184 | |
| Interaction | RNF123 interactions | UBQLNL SIN3B LAMB4 SPOUT1 LAMA1 INTS1 GRIK1 ECPAS PARVG FMNL2 BIRC6 MTPAP PTGS1 ADRA1A GTF3C1 ADAMTS9 UTP20 KDM8 RXFP1 | 7.39e-06 | 824 | 145 | 19 | int:RNF123 |
| Interaction | IFT20 interactions | 9.28e-06 | 143 | 145 | 8 | int:IFT20 | |
| Cytoband | 1q23.1 | 1.83e-05 | 46 | 155 | 4 | 1q23.1 | |
| GeneFamily | Olfactory receptors, family 10 | 7.07e-05 | 66 | 118 | 5 | 157 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 4.17e-04 | 5 | 118 | 2 | 1199 | |
| GeneFamily | EMI domain containing | 8.68e-04 | 7 | 118 | 2 | 540 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 1.15e-03 | 8 | 118 | 2 | 419 | |
| GeneFamily | SPOUT methyltranferase domain containing | 1.15e-03 | 8 | 118 | 2 | 1294 | |
| GeneFamily | Laminin subunits | 2.67e-03 | 12 | 118 | 2 | 626 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS | 7.72e-06 | 171 | 153 | 8 | M40275 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | GPD2 PDGFRA ACVR1 LYST PTGFRN PTGS1 PLAA RABEP1 ABTB2 HTT DNM2 | 1.49e-05 | 379 | 153 | 11 | M1885 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.79e-06 | 148 | 144 | 8 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | PDE3A ANGPT1 PDGFRA ACVR1 BIRC6 ELMO1 THBD C2CD3 TIAL1 GUCY1B1 CUX1 | 9.55e-06 | 312 | 144 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.15e-05 | 156 | 144 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | PDE3A ANGPT1 PDGFRA LAMA1 PCDHB11 MUC16 ACVR1 IL1RL2 THBD GUCY1B1 ITM2A | 1.90e-05 | 336 | 144 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | PDE3A ANGPT1 PDGFRA ECPAS ELMO1 SPAG5 C2CD3 AKAP9 TIAL1 GUCY1B1 CUX1 | 4.48e-05 | 369 | 144 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.42e-05 | 265 | 144 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 8.63e-05 | 207 | 144 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | MACC1 PDE3A ANGPT1 PDGFRA PCDHB11 ECPAS ELMO1 SPAG5 MFAP3 THBD C2CD3 AKAP9 TIAL1 GUCY1B1 CUX1 DNM2 | 1.19e-04 | 806 | 144 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.36e-04 | 165 | 144 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.48e-04 | 74 | 144 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.52e-04 | 168 | 144 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | PDE3A PDGFRA SYNE1 BIRC3 IL1RL2 LYST MAP3K5 CHST15 GUCY1B1 SCARB2 IL1R1 | 1.70e-04 | 429 | 144 | 11 | gudmap_kidney_adult_Mesangium_Meis_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.86e-04 | 122 | 144 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FRAS1 PDE3A ANGPT1 PDGFRA LAMA1 PCDHB11 MUC16 IL1RL2 THBD THBS1 GUCY1B1 ADAMTS9 IL1R1 ITM2A CUX1 | 2.64e-04 | 777 | 144 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.73e-04 | 310 | 144 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ANGPT1 ANK2 PDGFRA SYNE1 LAMA1 ACTN2 EMILIN1 THBS1 AKAP9 GTF3C1 IL1R1 | 1.17e-10 | 200 | 154 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.15e-08 | 198 | 154 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.43e-08 | 200 | 154 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.98e-07 | 187 | 154 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 190 | 154 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-07 | 191 | 154 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.64e-07 | 192 | 154 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.94e-07 | 194 | 154 | 8 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-07 | 196 | 154 | 8 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.96e-07 | 200 | 154 | 8 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.96e-07 | 200 | 154 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.96e-07 | 200 | 154 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-06 | 159 | 154 | 7 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 176 | 154 | 7 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 176 | 154 | 7 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-06 | 177 | 154 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-06 | 180 | 154 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-06 | 180 | 154 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-06 | 183 | 154 | 7 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 3.65e-06 | 184 | 154 | 7 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 185 | 154 | 7 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 185 | 154 | 7 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 185 | 154 | 7 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.06e-06 | 187 | 154 | 7 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 154 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 154 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.36e-06 | 189 | 154 | 7 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.51e-06 | 190 | 154 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 191 | 154 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 192 | 154 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.00e-06 | 193 | 154 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 194 | 154 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-06 | 194 | 154 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 194 | 154 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.17e-06 | 194 | 154 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 195 | 154 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-06 | 195 | 154 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-06 | 195 | 154 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 195 | 154 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 195 | 154 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 195 | 154 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.36e-06 | 127 | 154 | 6 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 196 | 154 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-06 | 197 | 154 | 7 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.91e-06 | 198 | 154 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.11e-06 | 199 | 154 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.11e-06 | 199 | 154 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.11e-06 | 199 | 154 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.31e-06 | 200 | 154 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 145 | 154 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 90 | 154 | 5 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 90 | 154 | 5 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-05 | 156 | 154 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 157 | 154 | 6 | 542944030cd9b3f3559e64f9f6598694d74003c0 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 169 | 154 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 169 | 154 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 173 | 154 | 6 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 173 | 154 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-05 | 175 | 154 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.42e-05 | 176 | 154 | 6 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 176 | 154 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 179 | 154 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 179 | 154 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.76e-05 | 179 | 154 | 6 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-05 | 179 | 154 | 6 | d5b9c610c1519804b1753fed1b505293ea590867 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 179 | 154 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-05 | 181 | 154 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.00e-05 | 181 | 154 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 182 | 154 | 6 | 0e589bf97d51b4b2f723f8c45853ad81b7ce8778 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 182 | 154 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 182 | 154 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 183 | 154 | 6 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 183 | 154 | 6 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 183 | 154 | 6 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.25e-05 | 183 | 154 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-05 | 184 | 154 | 6 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.39e-05 | 184 | 154 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| Disease | Brugada Syndrome (disorder) | 6.81e-06 | 24 | 153 | 4 | C1142166 | |
| Disease | Romano-Ward Syndrome | 7.29e-05 | 16 | 153 | 3 | C0035828 | |
| Disease | interleukin-1 receptor-like 2 measurement | 7.99e-05 | 3 | 153 | 2 | EFO_0801714 | |
| Disease | Huntington's disease (is_implicated_in) | 2.24e-04 | 23 | 153 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | cerebral white matter volume change measurement, age at assessment | 4.07e-04 | 28 | 153 | 3 | EFO_0008007, EFO_0021499 | |
| Disease | Malignant neoplasm of breast | PDE2A ANK2 SYNE1 GRIK2 ACVR1 PTGS1 SLC2A5 THBS1 NOP9 ARID1B ADRA1A LLGL1 AKAP9 UTP20 CUX1 | 4.87e-04 | 1074 | 153 | 15 | C0006142 |
| Disease | Breast Carcinoma | PDE2A SYNE1 GRIK2 ACVR1 PTGS1 SLC2A5 THBS1 NOP9 ARID1B LLGL1 | 5.24e-04 | 538 | 153 | 10 | C0678222 |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 7.33e-04 | 8 | 153 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.08e-04 | 139 | 153 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | ascending aortic diameter | 8.34e-04 | 140 | 153 | 5 | EFO_0021787 | |
| Disease | obesity (implicated_via_orthology) | 9.26e-04 | 215 | 153 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | interleukin 1 receptor-like 2 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0008169 | |
| Disease | interleukin-1 receptor type 1 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0020487 | |
| Disease | body fat percentage | 1.05e-03 | 488 | 153 | 9 | EFO_0007800 | |
| Disease | PR interval | 1.16e-03 | 495 | 153 | 9 | EFO_0004462 | |
| Disease | Creutzfeldt-Jakob disease (is_marker_for) | 1.17e-03 | 10 | 153 | 2 | DOID:11949 (is_marker_for) | |
| Disease | oral microbiome measurement | 1.35e-03 | 42 | 153 | 3 | EFO_0801229 | |
| Disease | cocaine use | 1.42e-03 | 11 | 153 | 2 | C3496069 | |
| Disease | interleukin 1 receptor-like 1 measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0008168 | |
| Disease | serum ST2 measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0005416 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.45e-03 | 43 | 153 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | Ischemic stroke | 1.56e-03 | 324 | 153 | 7 | HP_0002140 | |
| Disease | Mammary Carcinoma, Human | 1.74e-03 | 525 | 153 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.74e-03 | 525 | 153 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.78e-03 | 527 | 153 | 9 | C1458155 | |
| Disease | severe acute respiratory syndrome (is_marker_for) | 1.88e-03 | 47 | 153 | 3 | DOID:2945 (is_marker_for) | |
| Disease | melanoma | 1.92e-03 | 248 | 153 | 6 | C0025202 | |
| Disease | pancreatic cancer (is_marker_for) | 1.92e-03 | 101 | 153 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Manganese Poisoning | 2.33e-03 | 14 | 153 | 2 | C0677050 | |
| Disease | fibrinogen measurement | 2.54e-03 | 109 | 153 | 4 | EFO_0004623 | |
| Disease | interleukin 18 receptor 1 measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0008178 | |
| Disease | Malaria, susceptibility to | 3.06e-03 | 16 | 153 | 2 | cv:C1970028 | |
| Disease | – | 3.06e-03 | 16 | 153 | 2 | 611162 | |
| Disease | Drug habituation | 3.08e-03 | 115 | 153 | 4 | C0013170 | |
| Disease | Drug abuse | 3.08e-03 | 115 | 153 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.08e-03 | 115 | 153 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.08e-03 | 115 | 153 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.08e-03 | 115 | 153 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.08e-03 | 115 | 153 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.08e-03 | 115 | 153 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.08e-03 | 115 | 153 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.17e-03 | 116 | 153 | 4 | C0740858 | |
| Disease | response to radiation, Urinary retention | 3.45e-03 | 17 | 153 | 2 | GO_0009314, HP_0000016 | |
| Disease | thrombomodulin measurement | 3.45e-03 | 17 | 153 | 2 | EFO_0007774 | |
| Disease | ischemia (biomarker_via_orthology) | 3.87e-03 | 18 | 153 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Myopia | 4.07e-03 | 385 | 153 | 7 | HP_0000545 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.31e-03 | 19 | 153 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Astigmatism | 4.63e-03 | 129 | 153 | 4 | HP_0000483 | |
| Disease | Malaria | 4.77e-03 | 20 | 153 | 2 | C0024530 | |
| Disease | FEV/FEC ratio | DCHS2 FRAS1 PDE3A ACVR1 NEB ATP13A2 LIMK1 CROCC2 GYPB SLMAP ULK4 KCNS3 DNAH5 CUX1 | 4.84e-03 | 1228 | 153 | 14 | EFO_0004713 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTVLRILSQRSNDEV | 1666 | Q9UPW8 | |
| SSIILLDTLLLTENE | 456 | P41595 | |
| ISALTLRISELESQV | 2601 | Q99996 | |
| ILQISTVSLLETDIV | 521 | Q8NDM7 | |
| DQILLRRTTTITIES | 1331 | Q9HCK8 | |
| SAIDISILQRSLAIL | 191 | Q92556 | |
| LLLTTIARTINEVET | 726 | P35609 | |
| ILTSLVELTRFETLT | 1021 | Q9NR09 | |
| LLVINAITIALRTNS | 101 | Q7RTX7 | |
| IRLVFITTVVSTLLS | 121 | Q8TDN7 | |
| ILIFLESQITTLIVS | 676 | P02730 | |
| TLLSALVETRTIVRF | 381 | P01011 | |
| SSRLLETLENISTLV | 401 | Q5T601 | |
| TISLESLAVILAQLL | 301 | Q99965 | |
| VNLAVADLLLTSTVL | 66 | P35348 | |
| ITIETDILLSLLQSR | 281 | Q8NFD2 | |
| TDSLANRTLIVTTIL | 441 | P39086 | |
| QLTTLDTVSCLRIVL | 296 | Q04771 | |
| TQTSLQARELIDTIL | 486 | Q13489 | |
| TSRLEIQLLENSLST | 156 | Q15389 | |
| RLLDISISAVLNSLV | 2291 | Q8NFD5 | |
| TLDSLQRLFLIISAT | 41 | O43299 | |
| TDLLLQQVEATLTRE | 3346 | Q96M86 | |
| VLLSQVLLLTSAEDL | 11 | P55290 | |
| ESVLISSTVRLLESL | 46 | Q6ZW61 | |
| LRLQLERSIETSSTL | 1601 | Q96SN8 | |
| LLVREILGSQTALIT | 461 | Q09MP3 | |
| LTVVLEAVNRSLQLE | 106 | Q9HBI0 | |
| ISALVLRAQASEILL | 596 | Q15276 | |
| VSVTLLILDISRSEV | 116 | Q5VW38 | |
| NLLISLTFLTVTDLI | 511 | Q8TD20 | |
| LTRVTVVLLVAASDI | 136 | Q15334 | |
| TELLTEVASVRSRLL | 2496 | Q01484 | |
| LRSELTVAAAVLVLL | 521 | P16234 | |
| SSVLRTLNTLDINLE | 3901 | Q8WXI7 | |
| QTSSRLLEQVLLVLE | 326 | Q86U38 | |
| TLLLIILTDVFIIST | 226 | Q8NGY0 | |
| TILGNTTIILVSRLE | 41 | Q8NGZ5 | |
| IQTDSVLSARLQIIR | 3511 | Q86XX4 | |
| LLTLQNTSEFDILVI | 61 | P43304 | |
| IFQLDLITSEVTLLR | 761 | Q9NZR2 | |
| ITVRVLQALATLLSS | 1401 | Q8N201 | |
| VERSVVTLLQRATEL | 41 | Q8N371 | |
| LIARLEQDLSIIQSI | 441 | Q13948 | |
| SSVRTEALSVIELLL | 1781 | Q5VYK3 | |
| SVLLQEIITEARNLS | 411 | O00408 | |
| ALTSAVRTVSLISLE | 216 | Q14432 | |
| LAVLASLIIATNTLV | 11 | Q8TDV5 | |
| SLIIATNTLVAVAVL | 16 | Q8TDV5 | |
| LDTLRETQETLALTQ | 51 | Q13136 | |
| LIAISSLSVVLASIV | 186 | Q9BQ31 | |
| VELSRLATQVIISTR | 201 | O60774 | |
| TQELEILTDRLQLTL | 366 | Q02153 | |
| LTTNNRIALTSSELL | 326 | Q9NVV4 | |
| QLFQTTRLILIGETI | 326 | P23219 | |
| LQFISRESSLILAVT | 161 | P50570 | |
| SLELIALLLEAQATV | 61 | Q8WXE0 | |
| LIAFTITLILNVTRL | 156 | P55082 | |
| TVEVQAVLSALLTRI | 596 | Q6VY07 | |
| LVTLTSNVFIIIAIR | 36 | Q8NGY1 | |
| LRSLTAQIVILDVND | 1601 | Q6V1P9 | |
| VLLLDTISTTQFLVE | 2506 | Q6V1P9 | |
| IRENSILGSLILIVS | 251 | Q9Y5F2 | |
| TLVESLLTILNEQVS | 196 | Q8IZE3 | |
| LLTILNEQVSADVLS | 201 | Q8IZE3 | |
| ERFTVLETRLLVSNV | 171 | Q9HB29 | |
| IFVLLLSEIVSISAL | 6 | P06028 | |
| LQFLAIDLVITTTVA | 961 | Q9NQ11 | |
| STDRIEQELLLQVLS | 841 | Q9P2N4 | |
| VVLLSSSVNDIQRLL | 351 | Q8NFZ0 | |
| ILAILRVLISQSTED | 1676 | P42858 | |
| RVLISQSTEDIVLSR | 1681 | P42858 | |
| LISEVVRSLLVVSDL | 2696 | P42858 | |
| VSLSLRAVIQSELLS | 661 | Q4AC94 | |
| VALQARLSEQTLLVE | 311 | H7BZ55 | |
| LTLLSSELEQRASTI | 141 | Q53HC0 | |
| LASILNRTETEATLL | 551 | Q4G0X9 | |
| ELESLNTVLSALLAV | 571 | Q9NSG2 | |
| EILTIVSLLSVDSVL | 521 | Q9H6R0 | |
| QESTQVLRELEISLR | 101 | Q96PY5 | |
| SETSLQSIRLLEALL | 1096 | Q99698 | |
| VLILVNSLEVLRVTA | 831 | Q6ZN28 | |
| VEALLSRTVRTQILT | 21 | O43736 | |
| STLVLLLSIAIFQRQ | 1006 | Q86Z14 | |
| ANTRNDLLTILDTLT | 1336 | A4D0S4 | |
| IILILSARSTQEIEI | 51 | A0ZSE6 | |
| SQVSEILSALERRVL | 491 | Q9Y6C2 | |
| VLRLTRTVLDLQSSL | 191 | Q9BXX0 | |
| RETLIIAVLVSASIA | 161 | Q969F0 | |
| ESLILERVQRDLSQT | 996 | A2RUR9 | |
| LRVVIITEELLANSL | 1261 | Q9NYQ7 | |
| DSLSNRSLIVTTILE | 426 | Q13002 | |
| LALLVAVTVFQRSLT | 16 | Q8NFL0 | |
| IASLTLNEEILARVV | 111 | P17655 | |
| AITLENTLVILSTVA | 161 | Q58EX2 | |
| ALALQTLLTLIVVDA | 431 | O60779 | |
| TLITVLNISEIESRF | 291 | P14778 | |
| VLASLTSLSLELEQL | 1516 | P25940 | |
| IRTEEAILISLAALQ | 351 | Q5T280 | |
| LIVLSSEVGISELRL | 81 | Q9BT04 | |
| QAFLELLNTLIDVTT | 1861 | Q8TE73 | |
| LLNTLIDVTTRDLSS | 1866 | Q8TE73 | |
| DTTVNEILTLIISVL | 201 | P30954 | |
| LISSLEEEVSILNRQ | 1226 | Q14980 | |
| TNAIIISTIVLDRAL | 41 | Q8NGX5 | |
| TNAIIISTIVLDRAL | 41 | Q6IF99 | |
| IEVLTADIVINLLLS | 306 | Q99683 | |
| LSLERVSVLEFLLQV | 766 | Q9P2B2 | |
| TGSRQVIIRVLELLT | 396 | Q86VV8 | |
| DVLLVSAIITVSLSV | 16 | O43581 | |
| LESLTIIVQSSLIVA | 16 | Q9NYV7 | |
| EFLVNSSRVLLDTIL | 201 | O75031 | |
| LTITSILETQDTELL | 131 | O75691 | |
| SRAVTQLRSLVIDLE | 196 | Q6P9F5 | |
| TVRSSVAADVISLLL | 61 | P07204 | |
| VALFQLSDVTLILSV | 491 | Q8NB59 | |
| LSITATTQALALIEL | 536 | Q96HN2 | |
| LVSVINLLTLLVFTS | 376 | Q9GZN6 | |
| DNLLSSLVILEVLSR | 436 | Q96R06 | |
| LQRLELSTDIQTIEL | 8466 | Q8NF91 | |
| QTVLTLIISFSRILA | 116 | Q5T4T1 | |
| RSQTVTDLLLTIDVT | 891 | Q8NDG6 | |
| VVVQTELRTLSGLLA | 301 | Q9Y4C2 | |
| RLNLALSLSLTETQV | 326 | Q15270 | |
| DITVNETLLFLVATL | 191 | Q8NGL2 | |
| VATSFELIIISRLLV | 121 | P22732 | |
| ITRQTNESLLILRAI | 1986 | P25391 | |
| NILDTSIILISFILL | 1501 | Q7Z443 | |
| DVLTLVLDLNFLLVS | 16 | Q9BY78 | |
| VVLETNLATIRVLES | 496 | O75182 | |
| LLVTSVTLLVARVFQ | 16 | Q14108 | |
| VSALTLATETVRSIL | 516 | P50991 | |
| AQLELRTLEQSLLAT | 321 | Q8N961 | |
| SIKLIINSITTRIEF | 151 | Q7LFX5 | |
| QIIRTLQLTSDSELA | 261 | Q9BXT8 | |
| LRESQISLLQLSTVE | 706 | Q9Y4G8 | |
| IASIDLILTSLAISR | 41 | Q9NYW3 | |
| LINIRVELSQATTAL | 596 | Q9Y2H5 | |
| VLELRGLRTIVTTLQ | 281 | P07996 | |
| LDFLIVNISLISLTA | 1221 | Q9Y5Y9 | |
| QQRLLESVVVLTLAL | 36 | Q5U3C3 | |
| LATLQRLLAITQEAS | 186 | Q14BN4 | |
| LSLISTILEVVQDLE | 726 | Q9Y263 | |
| ILLRLAEDVVTFQTL | 156 | Q9HAV4 | |
| VIQELAVDLRITIST | 736 | Q9C0B7 | |
| ISSLENLLASIIQRV | 396 | Q9HBX9 | |
| SLVVNAVLSAVLLRL | 286 | Q96G79 | |
| TESLQQLLDRALTSL | 461 | Q9UJT2 | |
| IFTELVVSNITRLID | 56 | Q14CB8 | |
| VSRLLLDNSEILLQT | 211 | Q8IYU4 | |
| VLAVTAIRENLISAL | 386 | P22102 | |
| LSLLQTELEEVRSAL | 841 | Q9H6N6 | |
| QIDESSEISNITLLL | 911 | O95789 | |
| LETLVLSRSLTQELQ | 281 | Q00G26 | |
| IRTLQSALEALTVLS | 926 | Q13395 | |
| IIEAVTNLRLIESLF | 621 | Q12789 | |
| LSRDVTEVLILQLFS | 16 | Q01085 | |
| SLRLLSETTSLLVNQ | 951 | Q96C45 | |
| RETLIRSLGIVEQLT | 601 | A6NNM8 | |
| TLVRQLAVLLNVLDS | 836 | Q5VV43 | |
| LLIQETSRLLQLTLE | 241 | P53667 | |
| NTVLALRNTLIESDL | 5601 | P20929 |